Ditropan and Innohep drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ditropan (oxybutynin chloride) and Innohep (tinzaparin sodium). Common drug interactions include cholestasis among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Ditropan and Innohep. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Ditropan?

Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.

What is Innohep?

Innohep has active ingredients of tinzaparin sodium. eHealthMe is studying from 9,243 Innohep users. Check the latest studies of Innohep.

On Jul, 10, 2026

19 people who take Ditropan and Innohep together, and have interactions are studied.

What are the common drug interactions of Ditropan and Innohep, by gender? *:

female:

Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Confusional state
Drug ineffective
Haemoglobin decreased
Hip fracture
Hyperkalaemia (damage to or disease of the kidney)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pulmonary embolism (blockage of the main artery of the lung)
Pyrexia (fever)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

Febrile neutropenia (fever with reduced white blood cells)
Coma (state of unconsciousness lasting more than six hours)
Hepatocellular injury (liver injury)
Urinary tract infection
Acute pulmonary oedema (sudden deposit of fluid in the lung))
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Confusional state

What are the common drug interactions of Ditropan and Innohep, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Drug ineffective
Pulmonary embolism (blockage of the main artery of the lung)

40-49:

n/a

50-59:

n/a

60+:

Febrile neutropenia (fever with reduced white blood cells)
Coma (state of unconsciousness lasting more than six hours)
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Haemoglobin decreased
Hip fracture
Hyperkalaemia (damage to or disease of the kidney)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pyrexia (fever)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Confusional state

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 9 people, 47.37%
Pain: 2 people, 10.53%
Central Nervous System Lymphoma (cancer of central nervous system forms in lymph tissue): 2 people, 10.53%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 10.53%
Urinary Retention (the inability to completely or partially empty the bladder): 1 person, 5.26%
Embolism Venous (embolus may pass into the arterial system): 1 person, 5.26%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.26%
Brain Abscess: 1 person, 5.26%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 5.26%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ditropan and Innohep?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously